Allegra Orthopaedics Limited announced it has engaged Robert Bell to lead the Technology and Innovation Division. Based in the USA, Robert's primary responsibility will be overall management of Allegra's innovation project, the Sr-HT-Gahnite Spinal Cage Device (Spinal Cage). Robert's responsibilities will extend to coordinating activities relating not only to the Spinal Cage project, but all future innovation ventures undertaken by Allegra. Robert will play a pivotal role as Allegra moves closer to obtaining FDA 510k clearance as it plans is to enter the North American spinal implant market, which accounts for a 40% revenue share of the global market, approximately $7.4 billion. He spent the past 6 years as Head of Global Market Development and most recently VP Marketing & Strategy at the LINK GmbH & Co (`LINK'), and their LinkBio Corp.